These results are in agreement with a recent study (22) showing that B cells from APDS patients failed to generate IgG+ PB in response to CD40L + IL-21 and indicated that elevated activation of PI3K pathway inhibited Ig gene CSR in B cells. Here, PIK3CD is linked to activated PI3K-delta syndrome.